Abstract:Loss of bone mass and strength is a common problem of advanced age in humans. Defective bone is also a primary finding in osteogenesis imperfecta (OI), a genetic condition most commonly caused by autosomal dominant mutations in the type I collagen genes. Although altered collagen has been proposed to correlate with cellular processes that underlie aging, the causal relationships between them in vivo have not yet been completely explored. Whether aging plays a promoting role in OI development or whether OI contributes to aging, also remains unknown. The PpiB gene encodes cyclophilin B (CypB), a prolyl isomerase residing in the endoplasmic reticulum required for normal assembly of collagen. Germline deletion or mutations of CypB in mice or humans cause autosomal recessive OI (type IX). Here, we show that mice lacking CypB develop early onset of aging-associated phenotypes, including kyphosis, fat reduction and weight loss, as well as abnormal teeth, skin, and muscle. Elevated senescence-associated beta-galactosidase (SA-β-Gal) activity was observed in fat tissues and in bone marrow-derived multipotent stromal cells. Protein levels of the cyclin-dependent kinase (cdk)-inhibitor p21-Cip1/Waf1, a well known senescence marker, were significantly elevated in CypB-deficient primary cells and mouse tissues. Importantly, loss of p21 in CypB knockout mice attenuated SA-β-Gal activity and delayed the development of kyphosis. In addition, less adipose tissue depot and higher SA-β-Gal activity were observed in a second OI model, Cola2 oim mutant mice. A potential upregulation of p21 was also revealed in a limited number of these mice. These findings suggest that some of the features in OI patients may be mediated in part through activation of the p21-dependent pathway, one of which is closely associated with senescence and aging. This study provides new mechanistic insight into relationships between OI and aging and raises the possibility of using senolytics drugs to treat OI in the future. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Cyclophilin D links programmed cell death and organismal aging in Podospora anserina

Cyclophilin D plays a critical role in the survival of senescent cells

Impaired F1Fo-ATP-Synthase Dimerization Leads to the Induction of Cyclophilin D-Mediated Autophagy-Dependent Cell Death and Accelerated Aging

Cyclophilin D Knock-Out Mice Show Enhanced Resistance to Osteoporosis and to Metabolic Changes Observed in Aging Bone

Cyclophilin D: Guardian or Executioner for Tumor Cells?

Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing

Programmed cell death in aging

Cyclophilin D as a drug target

Accelerated Aging in Cyclophilin B-Deficient Mice Downstream of p21-Cip1/Waf1

Behead and live long or the tale of cathepsin L

Muscle-specific programmed cell death 5 deletion attenuates cardiac aging

Coupling of autophagy and the mitochondrial intrinsic apoptosis pathway modulates proteostasis and ageing in Caenorhabditis elegans

Cyclophilin D, regulator of the mitochondrial permeability transition, impacts bone development and fracture repair

Cyclophilin D induces necrotic core formation by mediating mitochondria-associated macrophage death in advanced atherosclerotic lesions

PGC-1α Modulates Telomere Function and DNA Damage in Protecting Against Aging-Related Chronic Diseases.

Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice

The effects of CypA on apoptosis: potential target for the treatment of diseases

PAS kinase deficiency reduces aging effects in mice

Mitochondrial pathways governing stress resistance, life, and death in the fungal aging model Podospora anserina